NASDAQ:CNCE
Delisted

Concert Pharmaceuticals Stock Signals

etoro logo Buy CNCE
*Your capital is at risk
$8.37
+0 (+0%)
At Close: May 30, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Concert Pharmaceuticals

General

Signal Type Signal Value Data
Score 0.000 109 days ( -73.65 %
Last Price $8.37 0 %
Performance History
7 Days
$8.37 $8.37
0%
30 Days
$8.37 $8.37
0%
12 Mos
$5.88 $8.37
42.35%

11/18

Active Buy Signals

Specific Signals

Short Term
Net score: 60.14
Signal Type Signal Value Importance Data
High / Low N/A Very Low $8.37 - $8.37
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low May 26, 2023 - 2 days
RSI Short Pivot Signal Buy Very Low Mar 21, 2023 - 49 days
Short MA 3 mos Buy Low Mar 09, 2023 - 57 days
Long MA 3 mos Buy Medium Apr 19, 2023 - 29 days
Short/Long MA 3 mos Buy Medium Apr 19, 2023 - 29 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 79.92
Signal Type Signal Value Importance Data
Trend - 12 mos 61.61 % Very High Width: 71.50 %
Pred. range - 12 mos $9.98 - $17.12 High 19.26 % - 104.54 %
Short MA 12 mos Buy Very High Mar 16, 2023 - 52 days
Long MA 12 mos Buy Very High Dec 29, 2022 - 104 days
Short/Long MA 12 mos Buy Very High Jan 09, 2023 - 98 days
Pivot Long Sell Low Feb 27, 2023 - 65 days
RSI Long Pivot Signal Buy Low Mar 30, 2023 - 42 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CONCERT PHARMACEUTICALS
Concert Pharmaceuticals
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologi...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE